Real-World Clinical Effectiveness and Safety of Antifibrotics in Progressive Pulmonary Fibrosis Associated with Rheumatoid Arthritis
Abstract
Share and Cite
Narváez, J.; Aguilar-Coll, M.; Vicens-Zygmunt, V.; Alegre, J.J.; Bermudo, G.; Molina-Molina, M. Real-World Clinical Effectiveness and Safety of Antifibrotics in Progressive Pulmonary Fibrosis Associated with Rheumatoid Arthritis. J. Clin. Med. 2024, 13, 7074. https://doi.org/10.3390/jcm13237074
Narváez J, Aguilar-Coll M, Vicens-Zygmunt V, Alegre JJ, Bermudo G, Molina-Molina M. Real-World Clinical Effectiveness and Safety of Antifibrotics in Progressive Pulmonary Fibrosis Associated with Rheumatoid Arthritis. Journal of Clinical Medicine. 2024; 13(23):7074. https://doi.org/10.3390/jcm13237074
Chicago/Turabian StyleNarváez, Javier, Martí Aguilar-Coll, Vanesa Vicens-Zygmunt, Juan José Alegre, Guadalupe Bermudo, and María Molina-Molina. 2024. "Real-World Clinical Effectiveness and Safety of Antifibrotics in Progressive Pulmonary Fibrosis Associated with Rheumatoid Arthritis" Journal of Clinical Medicine 13, no. 23: 7074. https://doi.org/10.3390/jcm13237074
APA StyleNarváez, J., Aguilar-Coll, M., Vicens-Zygmunt, V., Alegre, J. J., Bermudo, G., & Molina-Molina, M. (2024). Real-World Clinical Effectiveness and Safety of Antifibrotics in Progressive Pulmonary Fibrosis Associated with Rheumatoid Arthritis. Journal of Clinical Medicine, 13(23), 7074. https://doi.org/10.3390/jcm13237074